The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Injecting drug use accounted for 9% of all new HIV infections in the USA in 2014 – but new demographic trends among people who inject drugs present new challenges for the HIV response.
The UK has exceeded UNAIDS Fast-Track targets of getting people on treatment and virally suppressed, but falls behind on reaching those who are undiagnosed.
Authorities in the Czech Republic have dropped their case against 30 HIV-positive gay men accused of having unprotected sex and spreading HIV – a criminal offence in the country.
Gay men living with HIV are 37 times more likely to develop anal cancer than HIV-negative gay men, but a lack of guidelines means these men don’t get screened.
The world’s fastest HIV testing kit is to be launched in the United Kingdom (UK) ahead of European HIV Testing Week (18-25 November).
The game-changing drug, Truvada – the only drug approved for PrEP – will be offered to groups considered at risk of HIV.
Phase III trials of the intravenous drug ibalizumab have been found to significantly reduce viral load in people living with HIV who do not respond to existing treatment.
The European Commission has given pharmaceutical company, Gilead, the green light to market Truvada as pre-exposure prophylaxis (PrEP) across the region.
The world’s largest drug consumption facility has opened in Copenhagen, Denmark, giving people who use drugs a safe place to use illicit substances in a way that will limit harm to themselves, and to those around them.
